Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

Market Tremors: S&P 500 Plunge Triggered by Trade Tensions

Andreas Sommer by Andreas Sommer
October 13, 2025
in Market Commentary, S&P 500, Tech & Software
0
S&P 500 Stock
0
SHARES
24
VIEWS
Share on FacebookShare on Twitter

A promising trading session turned into a significant sell-off for the S&P 500 this past Friday. The index initially climbed, reaching an intraday peak of 6,762.40 points. However, the market’s trajectory reversed sharply following midday comments from President Trump concerning escalating trade disputes with China. The benchmark index plummeted to a low of 6,550.78 points, ultimately closing the session at 6,552.51. This volatility triggered a massive surge in trading activity, with the NYSE recording a volume of 12.8 billion shares—the highest single-day figure since August.

Sector Performance and Key Movers

The sell-off was not evenly distributed, with the technology sector absorbing the most severe impact. Semiconductor and software companies were particularly hard-hit. Synopsys and Teradyne each plunged approximately 9%, while Advanced Micro Devices (AMD) and Microchip Technology registered losses of around 8%. Nvidia, a recent market darling that had hit a fresh record high earlier in the day, reversed course to finish nearly 5% lower. Tesla and Amazon followed the downward trend with similar declines. A lone bright spot emerged in the consumer staples sector, where PepsiCo shares jumped almost 4% on the back of stronger quarterly results and the announcement of a new Chief Financial Officer.

  • Trading Volume: 12.8 billion shares (highest since August)
  • Market Breadth: A 4:1 ratio of declining issues versus advancers
  • VIX Index: Surged 25.68% to 20.65 points

Technical Breakdown Signals Weakness

From a technical analysis perspective, the sharp reversal pushed the S&P 500 below several critical support levels. The index decisively broke through its 20-day moving average and proceeded to test its 50-day moving average, situated near the 6,525-point mark. Previous resistance levels in the 6,745 to 6,760-point range, which had previously provided support, were easily breached. Momentum indicators had already flashed warning signs earlier in the week; the Relative Strength Index (RSI), for instance, had been signaling overbought conditions with a reading above 70, suggesting the market was ripe for a pullback.

Should investors sell immediately? Or is it worth buying S&P 500?

Broader Market Correlations and Safe Havens

The downturn was a broad-based event, affecting all major U.S. equity indices. The Dow Jones Industrial Average fell 1.9%, while the technology-heavy Nasdaq Composite experienced a more severe drop of 3.6%. On a weekly basis, all major indices gave up more than 2.4% of their value. The flight from risk was also evident in other asset classes. As oil prices slumped to their lowest level since May, gold—a traditional safe-haven asset—benefited, climbing 1.5% to $4,035 per ounce.

Looking ahead, early indications from Sunday evening trading provided a glimmer of hope, with S&P 500 futures pointing to a 1.1% recovery. Rhetoric surrounding the trade conflicts also appeared to be calming, at least temporarily. The critical question for investors now is whether the support level around 6,500 points will hold firm, or if Friday’s dramatic plunge is a precursor to a more profound market correction.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from February 7 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Conduent Stock
Cyber Security

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

February 7, 2026
Communications Stock
Industrial

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Next Post
Nuscale Power Stock

Insider Exodus Casts Shadow Over NuScale Power's Nuclear Ambitions

Boeing Stock

Boeing Faces Mounting Regulatory Scrutiny Amid Safety Incidents

Qualcomm Stock

Chipmaker Qualcomm Faces Dual Threat from Trade Wars and Regulatory Scrutiny

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com